Renaissance Technologies
LEGN icon

Renaissance Technologies’s Legend Biotech LEGN Stock Holding History

Renaissance Technologies’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.9M Buy
1,000,200
+478,400
+92% +$12.9M 0.04% 549
2026
Q1 		$9.44M Buy
521,800
+119,000
+30% +$2.27M 0.01% 998
2025
Q4 		$8.76M Sell
402,800
-440,400
-52% -$12.6M 0.01% 985
2025
Q3 		$27.5M Buy
843,200
+186,900
+28% +$6.9M 0.04% 586
2025
Q2 		$23.3M Sell
656,300
-54,600
-8% -$1.77M 0.03% 639
2025
Q1 		$24.1M Sell
710,900
-197,200
-22% -$7.07M 0.04% 591
2024
Q4 		$29.5M Buy
908,100
+890,000
+4,917% +$36.9M 0.04% 492
2024
Q3 		$882K Buy
+18,100
New +$964K ﹤0.01% 2521
2024
Q1 		– Sell
-122,000
Closed -$7.34M – 3911
2023
Q4 		$7.34M Buy
122,000
+21,800
+22% +$1.38M 0.01% 1101
2023
Q3 		$6.73M Buy
100,200
+86,100
+611% +$5.98M 0.01% 1136
2023
Q2 		$973K Sell
14,100
-27,200
-66% -$1.78M ﹤0.01% 2479
2023
Q1 		$1.99M Buy
41,300
+10,400
+34% +$509K ﹤0.01% 2033
2022
Q4 		$1.54M Sell
30,900
-39,300
-56% -$1.9M ﹤0.01% 2244
2022
Q3 		$2.86M Buy
+70,200
New +$3.29M ﹤0.01% 1791
2022
Q2 		– Sell
-181,100
Closed -$6.58M – 4424
2022
Q1 		$6.58M Buy
+181,100
New +$7.16M 0.01% 1402
2021
Q3 		– Sell
-60,800
Closed -$2.5M – 3671
2021
Q2 		$2.5M Buy
+60,800
New +$2.07M ﹤0.01% 2101

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Renaissance Technologies's LEGN Position: Q2 2026 in Review

Renaissance Technologies increased its Legend Biotech (LEGN) stake by 92% in Q2 2026, buying an estimated $12.9M and bringing the position to 1,000,200 shares worth $28.9M. The position accounts for 0.04% of the portfolio, ranked #549.

Renaissance Technologies first reported a position in LEGN in Q2 2021 and has held it in 16 quarters since. The position peaked at $29.5M in Q4 2024. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Renaissance Technologies held 1,000,200 shares of Legend Biotech worth $28.9M as of Q2 2026.
  • Renaissance Technologies bought 478,400 Legend Biotech shares in Q2 2026, an estimated $12.9M.
  • Legend Biotech made up 0.04% of Renaissance Technologies's portfolio in Q2 2026, its #549 holding.
  • Renaissance Technologies first reported a position in Legend Biotech in Q2 2021 and has held it in 16 quarters since.
  • Renaissance Technologies's Legend Biotech position peaked at $29.5M in Q4 2024.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.